Assesses Noonan syndrome features including pulmonary stenosis severity, HCM risk, bleeding disorder (von Willebrand, platelet dysfunction), short stature SDS, and MEK/RAS pathway mutation for trametinib eligibility.
Use the full interactive calculator below, or